Literature DB >> 20128154

Prevalence of cardiovascular risk factors in an unselected italian population. Results of the Cardiolab Project 2004-2008.

Guido Grassi1, Francesca Arenare, Raffaella Dell'oro, Fosca Quarti-Trevano, Gianmaria Brambilla, Stefano Carugo, Michael Smith, Giuseppe Mancia.   

Abstract

OBJECTIVE: Screening and educational campaigns on cardiovascular (CV) risk factors are important for primary and secondary prevention of CV disease. The CardioLab project is an observational cross-sectional study aimed at determining the prevalence of CV risk factors in a large unselected sample of the Italian population leaving in northern, central and southern Italy. METHODS AND
RESULTS: Data collection included family and clinical history, anthropometric data, blood pressure, blood glucose and total cholesterol values. Individual CV risk profile was assessed throughout by the risk charts of both the Progetto Cuore and the Score Project. In 36,161 participants (56.3% men) with a mean age of 60 years a complete assessment of the above mentioned variables was obtained. 44.4% of the screened subjects was overweight, while approximately 20% of the population displayed an obese state with a body mass index >30 kg/m2. Alterations in blood glucose levels indicating the presence of glucose intolerance were identified in 11.5% of the population while 9.3% displayed overt diabetes. 36.1% and 42.3% had elevated total cholesterol levels (> 200 mg/dl) and blood pressure values (> or = 140/90 mmHg), respectively. New diagnosis of diabetes, hypercholesterolaemia and hypertension was obtained in 5.3%, 23.6% and 19.6%, respectively. Global assessment of the CV risk showed that approximately 12.6% of the population is at a high risk of CV events over a 10-year period.
CONCLUSIONS: This large-scale observational study provides important information on the CV risk profile of an unselected Italian population and underlines the need for a more aggressive identification and appropriate correction of CV risk factors.

Entities:  

Mesh:

Year:  2009        PMID: 20128154     DOI: 10.2143/AC.64.6.2044742

Source DB:  PubMed          Journal:  Acta Cardiol        ISSN: 0001-5385            Impact factor:   1.718


  4 in total

1.  Low rates of both lipid-lowering therapy use and achievement of low-density lipoprotein cholesterol targets in individuals at high-risk for cardiovascular disease across Europe.

Authors:  Julian P Halcox; Florence Tubach; Esther Lopez-Garcia; Guy De Backer; Claudio Borghi; Jean Dallongeville; Eliseo Guallar; Jesús Medina; Joep Perk; Ogün Sazova; Stephen Sweet; Carine Roy; José R Banegas; Fernando Rodriguez-Artalejo
Journal:  PLoS One       Date:  2015-02-18       Impact factor: 3.240

2.  Awareness, treatment, and control of major cardiovascular risk factors in a small-scale Italian community: results of a screening campaign.

Authors:  Stefano Omboni; Giorgia Carabelli; Edoardo Ghirardi; Stefano Carugo
Journal:  Vasc Health Risk Manag       Date:  2013-04-30

Review 3.  Impact of treatment with rosuvastatin and atorvastatin on cardiovascular outcomes: evidence from the Archimedes-simulated clinical trials.

Authors:  Furio Colivicchi; Catarina Sternhufvud; Sanjay K Gandhi
Journal:  Clinicoecon Outcomes Res       Date:  2015-11-27

4.  Prevalence of dyslipidaemia and awareness of blood cholesterol levels among community-living people: results from the Longevity check-up 7+ (Lookup 7+) cross-sectional survey.

Authors:  Emanuele Marzetti; Riccardo Calvani; Anna Picca; Alex Sisto; Matteo Tosato; Anna Maria Martone; Elena Ortolani; Sara Salini; Teodosio Pafundi; Angelo Santoliquido; Luca Santoro; Roberto Bernabei; Francesco Landi
Journal:  BMJ Open       Date:  2018-06-30       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.